139517-52-5Relevant articles and documents
Discovery of a necroptosis inhibitor improving dopaminergic neuronal loss after mptp exposure in mice
Oliveira, Sara R.,Dionísio, Pedro A.,Gaspar, Maria M.,Ferreira, Maria B. T.,Rodrigues, Catarina A. B.,Pereira, Rita G.,Estev?o, Mónica S.,Perry, Maria J.,Moreira, Rui,Afonso, Carlos A. M.,Amaral, Joana D.,Rodrigues, Cecília M. P.
, (2021/05/21)
Parkinson’s disease (PD) is the second most common neurodegenerative disorder, mainly characterized by motor deficits correlated with progressive dopaminergic neuronal loss in the substantia nigra pars compacta (SN). Necroptosis is a caspase-independent f
A MODIFICATION OF THE PLOECHL-ERLENMEYER REACTION. I. SYNTHESIS OF 2-PHENYL-4-DIPHENYLMETHYLENE-5(4H)-OXAZOLONE
Ivanova, Ginka G.
, p. 177 - 186 (2007/10/02)
An N-methylketimine has been found to be an effective reagent in the Erlenmeyer azlactone synthesis. 2-Phenyl-4-diphenylmethylene-5(4H)-oxazolone (1) has been synthesized by the reaction of 2-phenyl-5(4H)-oxazolone (A) with N-methyl-diphenylmethanimine (B